Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

William Masters

Graduate Fellow

London, UK

Latest From William Masters

Biotech Foundations: Networks And Lab Space Are As Crucial As Funding

BioInnovation Institute chief business officer Bobby Soni shares how the life sciences incubator sources entrepreneurs and science globally, and the range of tools it provides to translate this into commercially viable companies. 

StartUps and SMEs Financing

Lithuania Caps Off Decade Of Growth With Stellar 2020

Lithuania’s life sciences sector has harnessed the country’s talent, infrastructure and government support to realize a decade of unprecedented growth. With the industry now maturing, can the Baltic state overcome challenges to become a significant European player?

Growth Business Strategies

Execs On The Move, September 2021

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Executive Changes Leadership

Executives On The Move: New CEOs At ReWind And Esker Therapeutics

Hyloris picks up new chief financial officer, new chief medical officer joins Cyclo and more.

Executive Changes Leadership

Snapshot: August Highlights

A selection of articles you might have missed from August 2021, including exclusive interviews with industry leaders and a deep dive into the RNA therapy pipeline. 

Business Strategies Commercial

Kaiku Health To Build On 2020 Success With Rapid Expansion

With digital therapies and devices seeing widespread adoption in response to lockdown limitations during the COVID-19 pandemic, Kaiku Health is in a strong position to expand its patient monitoring software. CEO Lauri Sippola spoke with In Vivo about the platform and the company’s plans for 2021 and beyond.

Business Strategies Digital Health
See All
UsernamePublicRestriction

Register